The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Iohexol API Market Research Report 2025
Synopsis
Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
The global Iohexol API market was valued at US$ 506.1 million in 2023 and is anticipated to reach US$ 885.3 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
This report aims to provide a comprehensive presentation of the global market for Iohexol API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol API.
Report Scope
The Iohexol API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iohexol API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iohexol API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iohexol API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iohexol API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iohexol API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
The global Iohexol API market was valued at US$ 506.1 million in 2023 and is anticipated to reach US$ 885.3 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
This report aims to provide a comprehensive presentation of the global market for Iohexol API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol API.
Report Scope
The Iohexol API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iohexol API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iohexol API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iohexol API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iohexol API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iohexol API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Iohexol API Market Overview
1.1 Product Definition
1.2 Iohexol API Segment by Type
1.2.1 Global Iohexol API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Iohexol API Segment by Application
1.3.1 Global Iohexol API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Market Growth Prospects
1.4.1 Global Iohexol API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Iohexol API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Iohexol API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Iohexol API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iohexol API Production Market Share by Manufacturers (2019-2024)
2.2 Global Iohexol API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Iohexol API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Iohexol API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Iohexol API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Iohexol API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Iohexol API, Product Offered and Application
2.8 Global Key Manufacturers of Iohexol API, Date of Enter into This Industry
2.9 Iohexol API Market Competitive Situation and Trends
2.9.1 Iohexol API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Iohexol API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Iohexol API Production by Region
3.1 Global Iohexol API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Iohexol API Production Value by Region (2019-2030)
3.2.1 Global Iohexol API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Iohexol API by Region (2025-2030)
3.3 Global Iohexol API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Iohexol API Production by Region (2019-2030)
3.4.1 Global Iohexol API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Iohexol API by Region (2025-2030)
3.5 Global Iohexol API Market Price Analysis by Region (2019-2024)
3.6 Global Iohexol API Production and Value, Year-over-Year Growth
3.6.1 North America Iohexol API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Iohexol API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Iohexol API Production Value Estimates and Forecasts (2019-2030)
4 Iohexol API Consumption by Region
4.1 Global Iohexol API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Iohexol API Consumption by Region (2019-2030)
4.2.1 Global Iohexol API Consumption by Region (2019-2024)
4.2.2 Global Iohexol API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Iohexol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Iohexol API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iohexol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Iohexol API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iohexol API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Iohexol API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iohexol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Iohexol API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Iohexol API Production by Type (2019-2030)
5.1.1 Global Iohexol API Production by Type (2019-2024)
5.1.2 Global Iohexol API Production by Type (2025-2030)
5.1.3 Global Iohexol API Production Market Share by Type (2019-2030)
5.2 Global Iohexol API Production Value by Type (2019-2030)
5.2.1 Global Iohexol API Production Value by Type (2019-2024)
5.2.2 Global Iohexol API Production Value by Type (2025-2030)
5.2.3 Global Iohexol API Production Value Market Share by Type (2019-2030)
5.3 Global Iohexol API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Iohexol API Production by Application (2019-2030)
6.1.1 Global Iohexol API Production by Application (2019-2024)
6.1.2 Global Iohexol API Production by Application (2025-2030)
6.1.3 Global Iohexol API Production Market Share by Application (2019-2030)
6.2 Global Iohexol API Production Value by Application (2019-2030)
6.2.1 Global Iohexol API Production Value by Application (2019-2024)
6.2.2 Global Iohexol API Production Value by Application (2025-2030)
6.2.3 Global Iohexol API Production Value Market Share by Application (2019-2030)
6.3 Global Iohexol API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 GE Healthcare
7.1.1 GE Healthcare Iohexol API Corporation Information
7.1.2 GE Healthcare Iohexol API Product Portfolio
7.1.3 GE Healthcare Iohexol API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 GE Healthcare Main Business and Markets Served
7.1.5 GE Healthcare Recent Developments/Updates
7.2 Otsuka Chemicals
7.2.1 Otsuka Chemicals Iohexol API Corporation Information
7.2.2 Otsuka Chemicals Iohexol API Product Portfolio
7.2.3 Otsuka Chemicals Iohexol API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Otsuka Chemicals Main Business and Markets Served
7.2.5 Otsuka Chemicals Recent Developments/Updates
7.3 Justesa Imagen
7.3.1 Justesa Imagen Iohexol API Corporation Information
7.3.2 Justesa Imagen Iohexol API Product Portfolio
7.3.3 Justesa Imagen Iohexol API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Justesa Imagen Main Business and Markets Served
7.3.5 Justesa Imagen Recent Developments/Updates
7.4 Starry Pharmaceutical
7.4.1 Starry Pharmaceutical Iohexol API Corporation Information
7.4.2 Starry Pharmaceutical Iohexol API Product Portfolio
7.4.3 Starry Pharmaceutical Iohexol API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Starry Pharmaceutical Main Business and Markets Served
7.4.5 Starry Pharmaceutical Recent Developments/Updates
7.5 Haichang Pharmaceutical
7.5.1 Haichang Pharmaceutical Iohexol API Corporation Information
7.5.2 Haichang Pharmaceutical Iohexol API Product Portfolio
7.5.3 Haichang Pharmaceutical Iohexol API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Haichang Pharmaceutical Main Business and Markets Served
7.5.5 Haichang Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iohexol API Industry Chain Analysis
8.2 Iohexol API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iohexol API Production Mode & Process
8.4 Iohexol API Sales and Marketing
8.4.1 Iohexol API Sales Channels
8.4.2 Iohexol API Distributors
8.5 Iohexol API Customers
9 Iohexol API Market Dynamics
9.1 Iohexol API Industry Trends
9.2 Iohexol API Market Drivers
9.3 Iohexol API Market Challenges
9.4 Iohexol API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
